Status:
COMPLETED
microRNA Expression in Renal Cell Carcinoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
Carcinoma, Renal Cell
Eligibility:
All Genders
18+ years
Brief Summary
In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomar...
Detailed Description
Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biolo...
Eligibility Criteria
Inclusion
- Patients with primary renal cell carcinoma.
- Subjects who agree to participate in the study and sign the informed consent.
Exclusion
- Patients with secondary renal cell carcinoma.
- Subjects who refuse to participate in the study and sign the informed consent.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00743054
Start Date
July 1 2008
End Date
August 1 2011
Last Update
May 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The 1st Affiliated Hospital, Sun Yet-sen University
Guangzhou, Guangdong, China, 510080